Brief: Dogwood Therapeutics Regains Nasdaq Compliance
03/04/2025 14:03
April 3 (Reuters) - Dogwood Therapeutics Inc DWTX.O: DOGWOOD THERAPEUTICS, INC. REGAINS NASDAQ COMPLIANCE Source text: ID:nGNXbvbtFq Further company coverage: DWTX.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study